Ken Mariash Presents Sinaptica Therapeutics at LSI USA '23

Sinaptica has developed a personalized closed-loop noninvasive neuromodulation therapy for Alzheimer’s Disease (AD).
Join Our Next Event
Partner with the leaders
shaping the future of
Medtech at LSI USA ‘26
March 16th - 20th, 2026
Waldorf Astoria, Monarch Beach
Speakers
Ken Mariash
Ken Mariash
CEO, Sinaptica Therapeutics